Community screening for osteoporosis could prevent more than a quarter of hip fractures in older women — according to new research led by the University of East Anglia (UEA).
A new study published today in The Lancet reveals that a simple questionnaire, combined with bone mineral density measurements for some, would help identify those at risk of hip fracture.
The research, which involved more than 12,000 older women, found that screening through GP practices allowed patients to be targeted for treatment.
In women agreeing to participate, this led to a 28 percent reduction in hip fractures over five years.
Lead researcher Prof Lee Shepstone, from UEA’s Norwich Medical School, said:
“Approximately one in three women and one in five men aged over 50 years will suffer a fragility fracture during their remaining lifetime. In the UK around 536,000 people suffer fragility fractures each year, including 79,000 hip fractures.
“A hip fracture can be devastating with a loss of independence and less than one-third of patients make a full recovery. Mortality at one-year post-fracture is approximately 20 percent.”
“We wanted to find out whether screening, like screening for breast cancer, could help identify those at risk of suffering a fracture.”
The large multicentre UK-based community screening study was a collaboration primarily between UEA and the University of Sheffield, and involved researchers at the Universities of Southampton, Bristol, Birmingham, Manchester and York, and over 100 primary care practices.
The team used a University of Sheffield developed tool called FRAX, which predicts the probability of a hip fracture or a major osteoporotic fracture (a hip, spine, upper arm or lower arm fracture), to identify older women at high risk.
A total of 12,483 women aged 70-85 were recruited from 100 GP practices in seven regions (Birmingham, Bristol, Manchester, Norwich, Sheffield, Southampton, and York).
Half of the women were screened to compare screening with routine care.
Among those screened, treatment was subsequently recommended for one in seven women deemed at high risk of hip fracture. This recommendation was acted upon by the women and their GPs so that over three-quarters of the women at high risk were on osteoporosis medications within six months of screening.
While screening did not reduce the incidence of all osteoporosis-related fractures, there was strong evidence for a reduction in hip fractures.
In the screening group, there were 54 fewer women who suffered one or more hip fractures compared to the routine care group.
The study suggests that one hip fracture could be prevented for every 111 women screened and early analysis suggests the approach is likely to be cost-effective.
Prof Shepstone said: “This is the first trial to show that a community-screening approach based on the FRAX fracture risk tool is both feasible and effective. Given that the number of costly and debilitating hip fractures are expected to increase with an aging population, the results of this study potentially have important public health implications.”
Prof Eugene McCloskey, University of Sheffield, said: “Low-cost screening with FRAX among the older population could result in effective, targeted intervention to reduce the human and socioeconomic burden of hip fractures. If the SCOOP screening strategy was taken up in exactly the same way as in the study in all UK women aged 70-85 years, we estimate that the strategy could prevent up to 8000 hip fractures per year in the UK. Even greater gains could be made if we could reach out to women similar to those who did not take part in the study.”
The randomized controlled trial ‘SCreening for Osteoporosis in Older women for the Prevention of fracture’ (SCOOP) was funded by the Medical Research Council and Arthritis Research UK.
Dr. Natalie Carter, head of research liaison and evaluation at Arthritis Research UK, said:”Ten of thousands of people a year present with hip fractures in the UK. As well as significantly increased mortality, a hip fracture can stop a person’s ability to live independently, with 43% no longer being able to walk independently in the year after the fracture.
We welcome this community-based screening programme and any other research that reduces the likelihood of fractures.”
Journal Reference:1. Lee Shepstone, Elizabeth Lenaghan, Cyrus Cooper, Shane Clarke, Rebekah Fong-Soe-Khioe, Richard Fordham, Neil Gittoes, Ian Harvey, Nick Harvey, Alison Heawood, Richard Holland, Amanda Howe, John Kanis, Tarnya Marshall, Terence O’Neill, Tim Peters, Niamh Redmond, David Torgerson, David Turner, Eugene McCloskey, Lee Shepstone, Elizabeth Lenaghan, Cyrus Cooper, Shane Clarke, Rebekah Fong-Soe-Khioe, Ric Fordham, Neil Gittoes, Ian Harvey, Nick Harvey, Alison Heawood, Richard Holland, Amanda Howe, John Kanis, Tarnya Marshall, Terence O’Neill, Tim Peters, Niamh Redmond, David Torgerson, David Turner, Eugene McCloskey, Nicola Crabtree, Helen Duffy, Jim Parle, Farzana Rashid, Katie Stant, Kate Taylor, Clare Thomas, Emma Knox, Cherry Tenneson, Helen Williams, David Adams, Veronica Bion, Jeanette Blacklock, Tony Dyer, Selina Bratherton, Matt Fidler, Katharine Knight, Carol McGurk, Katie Smith, Stacey Young, Karen Collins, Janet Cushnaghan, Catherine Arundel, Kerry Bell, Laura Clark, Sue Collins, Sarah Gardner, Natasha Mitchell. Screening in the community to reduce fractures in older women (SCOOP): a randomized controlled trial. The Lancet, 2017; DOI: 10.1016/S0140-6736(17)32640-5